How to buy Ginkgo Bioworks stock in Canada

Own Ginkgo Bioworks shares in just a few minutes.

Ginkgo Bioworks plans to go public by merging with special purpose acquisition company (SPAC), Soaring Eagle Acquisition Corp. But there’s no word yet on its anticipated release date or projected share price. Here's how investors in Canada can prepare to buy in when Ginkgo Bioworks finally goes public.

Our top picks for where to buy Ginkgo Bioworks stock

Best for Beginners

Go to site
Easy to use app
  • 100 free trades signup offer
  • Easy-to-use platform
  • Low fees
  • Student and young investor discounts

Best for Lowest Commissions

Go to site
Low margin rates
  • Access to international stock exchanges
  • Low margin rates
  • Powerful research tools

Best for Low Fees

Go to site
CA & US trading
  • 6% cash rebate plus $2,200 in trading perks
  • Low transaction fees
  • Easy-to-use app

How to buy Ginkgo Bioworks stock

  1. Choose a stock trading platform. Compare investment platforms.
  2. Open an account. Provide your personal information and sign up.
  3. Fund your account. Deposit funds into your account by linking your banking information or transfer funds from another trading account.
  4. Search for the stock name – DNA. Search for the stock by name or ticker symbol.
  5. Buy the stock. Place your order. It's that simple.

Buy Ginkgo Bioworks stock from these online trading platforms

Compare special offers, low fees and a wide range of investment options among top trading platforms.

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product CAFST Available Asset Types Account Types Stock Trading Fee Account Fee Offer
Interactive Brokers
Finder Score: 4.2 / 5: ★★★★★
Interactive Brokers
Stocks, Bonds, Options, Index Funds, ETFs, Currencies, Futures
RRSP, TFSA, Personal, Joint
min $1.00, max 0.5%
$0
CIBC Investor's Edge
Finder Score: 3.7 / 5: ★★★★★
OFFER
CIBC Investor's Edge
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal, Joint
$6.95
$0 if conditions met, or $100
Get 100 free trades when you open a CIBC Investor’s Edge account using promo code EDGE2425. Plus, get $200 or more cash back. Valid until March 31, 2025.
Moomoo Financial Canada
Finder Score: 3.9 / 5: ★★★★★
CASHBACK
Moomoo Financial Canada
Stocks, Options, ETFs
RRSP, TFSA, Personal
$0.014/stock
$0
Enjoy a 6% cash rebate, plus $2,200 in trading perks.
RBC Direct Investing
Finder Score: 3.8 / 5: ★★★★★
RBC Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal, Joint, Business
$6.95 - $9.95
$0 if conditions met, otherwise $25/quarter
Questrade
Finder Score: 3.9 / 5: ★★★★★
Questrade
Stocks, Bonds, Options, Mutual Funds, ETFs, Forex, GICs, Precious Metals, IPOs
RRSP, RESP, RRIF, TFSA, Personal
$4.95 - $9.95
$0
Qtrade Direct Investing
Finder Score: 3.6 / 5: ★★★★★
OFFER
Qtrade Direct Investing
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
RRSP, RESP, RRIF, TFSA, Personal, Joint
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Get 1% cashback or more, a $150 sign-up bonus & unlimited free trades until April 30th, 2025.
loading

Ginkgo Bioworks stock price (NYSE: DNA)

Use our graph to track the performance of DNA stocks over time.

Ginkgo Bioworks stocks at a glance

Information last updated 2024-11-27.
Latest market close$9.61
52-week range$5.26 - $75.20
50-day moving average $7.88
200-day moving average $22.51
Wall St. target price$8.20
PE ratio N/A
Dividend yield N/A
Earnings per share (TTM) $-12.89

Is it a good time to buy Ginkgo Bioworks stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Ginkgo Bioworks price performance over time

Historical closes compared with the close of $8.7 from 2024-11-29

1 week (2024-11-26) 9.43%
1 month (2024-11-01) 12.26%
3 months (2024-09-03) 42.62%
6 months (2024-06-03) 1,506.35%
1 year (2023-12-01) 508.39%
2 years (2022-12-02) -89.07%
3 years (2021-12-03) 346
5 years (2019-11-30) N/A

Ginkgo Bioworks financials

Revenue TTM $218 million
Gross profit TTM $273.5 million
Return on assets TTM -20.92%
Return on equity TTM -63.51%
Profit margin -298.78%
Book value $14.65
Market Capitalization $457 million

TTM: trailing 12 months

Ginkgo Bioworks stock dividends

We're not expecting Ginkgo Bioworks to pay a dividend over the next 12 months.

Have Ginkgo Bioworks's stocks ever split?

Ginkgo Bioworks's stocks were split on a 1:40 basis on 19 August 2024 . So if you had owned 40 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Ginkgo Bioworks stocks – just the quantity. However, indirectly, the new 3900% higher stock price could have impacted the market appetite for Ginkgo Bioworks stocks, which in turn could have impacted Ginkgo Bioworks's stock price.

Ginkgo Bioworks stock price volatility

Over the last 12 months, Ginkgo Bioworks's stocks have ranged in value from as little as $5.26 up to $75.2. A popular way to gauge a stock's volatility is its "beta."

DNA.US volatility(beta: 1.1)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a stocks volatility in relation to the market. The market (NYSE average) beta is 1, while Ginkgo Bioworks's is 1.098. This would suggest that Ginkgo Bioworks's stocks are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Ginkgo Bioworks overview

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming in the United States. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. It serves pharma and biotech, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts..

Frequently asked questions

What percentage of Ginkgo Bioworks is owned by insiders or institutions?
Currently 6.146% of Ginkgo Bioworks stocks are held by insiders and 68.562% by institutions.
How many people work for Ginkgo Bioworks?
Latest data suggests 1,218 work at Ginkgo Bioworks.
When does the fiscal year end for Ginkgo Bioworks?
Ginkgo Bioworks's fiscal year ends in December.
Where is Ginkgo Bioworks based?
Ginkgo Bioworks's address is: 27 Drydock Avenue, Boston, MA, United States, 02210
What is Ginkgo Bioworks's ISIN number?
Ginkgo Bioworks's international securities identification number is: US37611X1000
Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site